Shareholders at Fujifilm have had a little break from the global economic woes due to the COVID-19 pandemic, as a drug made by a subsidiary arm of their company has been found to be effective in helping patients recover from the virus. Patients, no doubt, have even more to celebrate.
[ Read More ]Original author: Mike O'Leary